![]() The MassARRAY Analyzer 4 is a benchtop MALDI-TOF mass spectrometer specifically designed for genomic research applications. Its standard configuration holds up to two 96- or 384-well microtiter plates.* One plate of samples is transferred in less than 10 minutes. NEW YORK (GenomeWeb) Sequenom said after the close of the market Friday that it has sold its bioscience business, which includes its MassArray system, to Agena Bioscience for 31.8 million. Previously, the company announced a separate partnership with Diatech Pharmacogenetics to develop CE-marked lung and colon cancer panels for targeted testing for the European market.įor more information on Agena visit their SelectScience company profile.The MassARRAY Nanodispenser RS1000 is a benchtop dispensing instrument employing advanced robotics for the rapid transfer of nanoliter volumes of sample onto SpectroCHIP Arrays. The MassARRAY System enables targeted, multiplexed testing of actionable genetic variants, providing a highly cost-effective and robust workflow that is ideal for clinical labs. "We are proud to be chosen by DaRui, a leading molecular diagnostics company in China, which further validates the clinical utility of the MassARRAY System," Dansky commented. "We evaluated the MassARRAY System against our criteria including automation, ease of use, and flexibility for the clinical lab, and have selected it based on its proven performance." Targeted genotyping and CNV interrogation were accomplished by multiplex single-base extension using the MassARRAY platform (Agena Biosciences) and. Products were detected on a MassArray mass spectrophotometer and data were acquired in real time with MassArray RT software 4.0.0.2 (Agena Biosciences). "We see our partnership with Agena Bioscience as a key opportunity to offer cost-effective, targeted genetic tests to the market that will ultimately benefit more patients," said DaRui Chairman, Dr. Ming Li. DaRui Biotechnology will conduct the requisite in-country clinical trials and submit the tests to the Chinese Food and Drug Administration. Under the partnership Agena Bioscience and DaRui Biotechnology will co-develop and commercialize targeted, multiplexed tests for oncology and inherited diseases tailored to the needs of the Chinese market. "To further our efforts, we sought a strategic partner with extensive expertise in the clinical diagnostics market." This past year, we established a subsidiary office in Shanghai and grew more than fifty percent in revenue," said Pete Dansky, CEO. ![]() "The China Market is a significant opportunity for Agena Bioscience, representing twenty percent of our global business. LC-MS innovation: Improve analytical accuracyĪgena Bioscience today announced its partnership with DaRui Biotechnology to co-develop a menu of in vitro diagnostic tests for oncology and inherited diseases on its MassARRAY ® System for targeted genetic analysis. Agena Bioscience, the global manufacturer of the MassARRAY System for targeted genetic analysis, announced an exclusive distribution agreement with Alliance. Which microbioreactor modules are best for you ![]() Here, we provide a guide to using the MassARRAY System, from assay design, through mass spectrometry. ![]() Which solid support is right for your oligo synthesis? The MassARRAY System by Agena Bioscience is a benchtop mass spectrometer that provides sensitive, accurate, and rapid analysis of nucleic acid samples. The Agena Bioscience MassARRAY System is one such platform. Lab Automation, AI & Digital Transformation.Food Contamination: Quality, Safety & Authenticity SAN DIEGO, Ma/PRNewswire/ - Agena Bioscience®, a global provider of low-cost, high-throughput molecular testing solutions, today announced the launch of the MassARRAY® SARS-CoV-2. Supplementary Table X: List of mutations analysed using the Agena MassArray technology. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |